In this issue:
Concomitant and sequential treatment for early-stage unfavourable HL patients
Comparison of chemotherapy or chemotherapy plus radiotherapy
G-CSF effectiveness in reducing relapse in MDS and AML patients
Affect of different MAC regimens on adult AML patients
Efficacy and safety of blinatumomab monotherapy for R/R B-ALL
IR2 regimen in R/R DLBCL patients
Autologous and allogeneic humanised CD19-targeted CAR-T cell therapy
Prognostic factors and efficacy of allo-HSCT for noninfant childhood ALL patients
Efficacy and safety of chidamide and CCAG regimen, followed by DLI
R/R BRAF V6000E mutation positive HCL patients and dabrafenib plus trametinib
Please login below to download this issue (PDF)